VYGR vs. PPH
VYGR (Voyager Therapeutics, Inc.) is a stock, while PPH (VanEck Pharmaceutical ETF) is Health & Biotech Equities fund tracking the MVIS US Listed Pharmaceutical 25 Index. Over the past 10 years, VYGR returned -12.79%/yr vs 8.23%/yr for PPH. At a 0.31 correlation, their price movements are largely independent.
Performance
VYGR vs. PPH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, VYGR achieves a -19.34% return, which is significantly lower than PPH's 8.15% return. Over the past 10 years, VYGR has underperformed PPH with an annualized return of -12.79%, while PPH has yielded a comparatively higher 8.23% annualized return.
VYGR
- 1D
- 4.28%
- 1M
- -12.43%
- 6M
- -15.69%
- YTD
- -19.34%
- 1Y
- -1.55%
- 3Y*
- -30.66%
- 5Y*
- -1.45%
- 10Y*
- -12.79%
PPH
- 1D
- 0.15%
- 1M
- 6.17%
- 6M
- 5.94%
- YTD
- 8.15%
- 1Y
- 29.82%
- 3Y*
- 14.33%
- 5Y*
- 10.78%
- 10Y*
- 8.23%
VYGR vs. PPH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
VYGR Voyager Therapeutics, Inc. | -19.34% | -30.69% | -32.82% | 38.36% | 125.09% | -62.10% | -48.75% | 48.40% | -43.37% | 30.30% |
PPH VanEck Pharmaceutical ETF | 8.15% | 22.00% | 8.05% | 6.95% | 2.64% | 17.79% | 5.49% | 19.39% | -5.89% | 15.23% |
Correlation
The correlation between VYGR and PPH is 0.24, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.24 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.31 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.27 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.31 |
Correlation (All Time) Calculated using the full available price history since Nov 11, 2015 | 0.31 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
VYGR vs. PPH — Risk / Return Rank
VYGR
PPH
VYGR vs. PPH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Voyager Therapeutics, Inc. (VYGR) and VanEck Pharmaceutical ETF (PPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| VYGR | PPH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.67 | ||
| Sortino ratioReturn per unit of downside risk | -2.10 | ||
| Omega ratioGain probability vs. loss probability | 1.05 | 1.29 | -0.24 |
| Calmar ratioReturn relative to maximum drawdown | -0.04 | 2.78 | -2.82 |
| Martin ratioReturn relative to average drawdown | -0.07 | 6.75 | -6.82 |
Loading charts...
Drawdowns
VYGR vs. PPH - Drawdown Comparison
The maximum VYGR drawdown since its inception was -92.11%, which is greater than PPH's maximum drawdown of -51.45%. Use the drawdown chart below to compare losses from any high point for VYGR and PPH.
Loading charts...
Drawdown Indicators
| VYGR | PPH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -92.11% | -51.45% | -40.66% |
Max Drawdown (1Y)Largest decline over 1 year | -42.96% | -10.76% | -32.20% |
Max Drawdown (3Y)Largest decline over 3 years | -74.82% | -18.06% | -56.76% |
Max Drawdown (5Y)Largest decline over 5 years | -80.49% | -20.26% | -60.23% |
Max Drawdown (10Y)Largest decline over 10 years | -92.11% | -29.70% | -62.41% |
Current DrawdownCurrent decline from peak | -89.88% | -1.40% | -88.48% |
Average DrawdownAverage peak-to-trough decline | -67.09% | -17.25% | -49.84% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 23.19% | 4.43% | +18.76% |
Volatility
VYGR vs. PPH - Volatility Comparison
Voyager Therapeutics, Inc. (VYGR) has a higher volatility of 15.67% compared to VanEck Pharmaceutical ETF (PPH) at 6.50%. This indicates that VYGR's price experiences larger fluctuations and is considered to be riskier than PPH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| VYGR | PPH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.67% | 6.50% | +9.17% |
Volatility (6M)Calculated over the trailing 6-month period | 44.88% | 13.24% | +31.64% |
Volatility (1Y)Calculated over the trailing 1-year period | 64.06% | 18.27% | +45.79% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 80.90% | 15.36% | +65.54% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 75.71% | 17.01% | +58.70% |
Dividends
VYGR vs. PPH - Dividend Comparison
VYGR has not paid dividends to shareholders, while PPH's dividend yield for the trailing twelve months is around 1.97%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PPH VanEck Pharmaceutical ETF | 1.97% | 1.78% | 1.98% | 2.09% | 1.55% | 1.62% | 1.66% | 1.77% | 1.97% | 1.92% | 2.43% | 1.93% |
VYGR Voyager Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
VYGR and PPH have a correlation of 0.24, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
VYGR has higher volatility (15.67%) compared to PPH (6.50%). In terms of maximum drawdown, VYGR dropped -92.11% vs PPH's -51.45%.
PPH currently has the higher Sharpe Ratio (1.65 vs -0.02), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for VYGR and PPH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer